Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New SCAI President Dawn Abbott outlines workforce, training and inclusion priorities
SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.
Boston Scientific pacemakers recalled again—software update now available
The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.
Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
Multiple GLP-1 drugs linked to lower AFib risk
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.
Current political climate having 'detrimental' effect on radiology research, survey says
Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers.

The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26

New SCAI President Dawn Abbott outlines workforce, training and inclusion priorities

SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.

FDA recall medical device recall product recall

Boston Scientific pacemakers recalled again—software update now available

The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

Multiple GLP-1 drugs linked to lower AFib risk

The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.

survey polling quick data check mark poll research doctor

Current political climate having 'detrimental' effect on radiology research, survey says

Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers.

Example of a RF burn from an MRI scan where a sedated patient's identification bracelet was touching their skin during an exam. Image courtesy of RSNA. https://pubs.rsna.org/doi/10.1148/radiol.09090637

FDA: CVS and MediHoney wound gels recalled after 14 serious injuries

The wound and burn gels are manufactured by Integra LifeSciences. Defective packaging could cause the sterile barrier to fail, exposing the gels to pathogens. Due to the risk of severe infections, all recalled products must be removed from where they are used and sold.

heart data research doctor cardiologist AI

Two separate studies explored the value of treating heart patients with tirzepatide.

Emily Lau, MD, MPH, Director, Women's Heart Health Program, Brigham and Women's Hospital, presented new data at ACC 2026 showing only 8% of high-risk pregnant patients receive guideline-recommended low-dose aspirin to prevent preeclampsia.

Many high-risk pregnant patients still miss out on guideline-recommended care

The percentage of pregnant patients taking low-dose aspirin as recommended is slowly rising—but there is still a long way to go.